SARS-CoV-2 Main Protease Inhibitors: Physics-based Approaches to the Discovery of COVID-19 Antivirals

DATE

November 18, 2021

TIME

10:00 a.m. PDT, 1:00 p.m. EDT, 18:00 BST, 19:00 CEST

Duration: 60 Minutes

Overview

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Worldwide, there have been over 240 million cases reported and close to 5 million deaths. Even though there are now several vaccines available for the disease, there is a clear need for the development of small molecule antivirals. One approach to the rapid discovery of such therapeutics is to apply physics-based methods to structures of the SARS-CoV-2 main protease, a key enzyme in the viral replication process. This talk will focus on the medicinal and computational chemistry driven discovery of main protease inhibitors. The challenges of coordinating this multi-company effort, the use of WaterMap to guide the design of inhibitors, and the use of Free-Energy Perturbation (FEP+) to predict the potencies of compounds to prioritize them for synthesis will be discussed. Biological results for key compounds will be presented.

Funding for this work is provided by Takeda, Schrödinger, Gilead, WuXi, and Google.

Key Learning Objectives:

The role computational chemistry played in the discovery of main protease inhibitors
Overcoming challenges of coordinating a multi-company project
How Schrödinger’s tools assisted in both design and prediction

Who Should Attend:

Computational Chemists
Medicinal Chemists
Drug Discovery Scientists

Brought to you by:

Speakers

Dr. Leah Frye
Distinguished Fellow,
Schrödinger

Dr. Abba E. Leffler
Principal Scientist,
Schrödinger

Dr. Daniel Carney
Senior Scientist,
Takeda Pharmaceuticals

Catherine Dold
Health & Environment Writer,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title

Department*

City*

State

Zip / Post Code

Country*

Business Phone

Account Type:*

Current computational tools you use:

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars